Volume

Lipid metabolic reprogramming as an emerging mechanism of resistance to kinase inhibitors in breast cancer

Topoisomerase IB: a relaxing enzyme for stressed DNA

How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance

The importance of epithelial-mesenchymal transition and autophagy in cancer drug resistance

Cyclin-dependent kinase inhibitors in brain cancer: current state and future directions

Predictive value of exosomes and their cargo in drug response/resistance of breast cancer patients

Detection of circulating tumor cells in blood of pancreatic ductal adenocarcinoma patients

Circulating tumor cells and drug history in primary breast cancer patients

Acknowledgement to reviewers of <i>Cancer Drug Resistance</i> in 2019

Epigenetic basis of cancer drug resistance

Actions for 0 selected articles

Cancer Drug Resistance
ISSN 2578-532X (Online)
Follow Us

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/